id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1975-N-0012-0320,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Chain Drug Chain Drug Consortium Beijing China,Other,Letter(s),2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2014-01-05T03:25:12Z,,0,0,09000064814b004f
FDA-1975-N-0012-0318,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Certus Medical  Inc,Other,Letter(s),2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2014-01-05T03:25:12Z,,0,0,09000064814b004d
FDA-1975-N-0012-0321,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Chain Drug Chain Drug Consortium Shanghai China,Other,Letter(s),2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2014-01-05T03:25:12Z,,0,0,09000064814b0050
FDA-1975-N-0012-0319,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Chain Drug Constortium Israel,Other,Letter(s),2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2014-01-05T03:25:12Z,,0,0,09000064814b004e
FDA-1975-N-0012-0317,FDA,FDA-1975-N-0012,"Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial
Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Reopening of Administrative Record",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2013-12-17T05:00:00Z,2013,12,2013-12-17T05:00:00Z,2015-02-17T04:59:59Z,2018-02-16T22:20:40Z,2013-29814,0,0,09000064814c4d8a
FDA-1975-N-0012-0309,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Cardinal Health Shanghai  China,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b0047
FDA-1975-N-0012-0304,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Beijing Ruicheng Medical Beijing China,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b0042
FDA-1975-N-0012-0307,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Canadian Custom  CAN,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b0045
FDA-1975-N-0012-0305,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re BioActive IA USA,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b0043
FDA-1975-N-0012-0313,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re CareFusion UT USA,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b004b
FDA-1975-N-0012-0296,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures  for  OTC Topical Antiseptic Drug Products Request Labeling Changes  re Amerisource Shanghai  China,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:10Z,,0,0,09000064814affae
FDA-1975-N-0012-0308,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Cardinal Health China,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b0046
FDA-1975-N-0012-0312,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re CareFusion CA Mexico USA,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b004a
FDA-1975-N-0012-0301,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures  for  OTC Topical Antiseptic Drug Products Request Labeling Changes  re Becton Dickinson IL  USA,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b003f
FDA-1975-N-0012-0298,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures  for  OTC Topical Antiseptic Drug Products Request Labeling Changes re Aplicare Inc  CT,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b003c
FDA-1975-N-0012-0297,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures  for  OTC Topical Antiseptic Drug Products Request Labeling Changes  re Amerisource Xintai China,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:10Z,,0,0,09000064814affaf
FDA-1975-N-0012-0295,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures  for  OTC Topical Antiseptic Drug Products Request Labeling Changes  re Amerisource Bergen WI USA,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:10Z,,0,0,09000064814affad
FDA-1975-N-0012-0303,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Becton UT USA,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b0041
FDA-1975-N-0012-0314,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Caribbean Medical  China,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b004c
FDA-1975-N-0012-0299,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures  for  OTC Topical Antiseptic Drug Products Request Labeling Changes  re Apotheca  USA,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b003d
FDA-1975-N-0012-0302,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures  for  OTC Topical Antiseptic Drug Products Request Labeling Changes  re Becton Dickinson NE USA,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b0040
FDA-1975-N-0012-0306,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Buttner Frank GmbH Taizhou Jingsu China,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b0044
FDA-1975-N-0012-0316,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Aplicare WV,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:10Z,,0,0,09000064814b003b
FDA-1975-N-0012-0311,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Cardinal Health USA,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b0049
FDA-1975-N-0012-0310,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Cardinal Health Texarkana TX USA,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b0048
FDA-1975-N-0012-0300,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures  for  OTC Topical Antiseptic Drug Products Request Labeling Changes  re Baoying Ctry Fukang Med Jiangsu China,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:11Z,,0,0,09000064814b003e
FDA-1975-N-0012-0315,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Amsino Jiangsu China,Other,Letter(s),2013-12-11T05:00:00Z,2013,12,2013-12-11T05:00:00Z,,2014-01-05T03:25:10Z,,0,0,09000064814affb0
FDA-1975-N-0012-0290,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes  re American Sales Xintai China,Other,Letter(s),2013-12-07T05:00:00Z,2013,12,2013-12-07T05:00:00Z,,2014-01-05T03:25:10Z,,0,0,09000064814affac
FDA-1975-N-0012-0291,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures  for OTC Topical Antiseptic Drug Products Request Labeling Changes  re American Sales Shanghai  China,Other,Letter(s),2013-12-07T05:00:00Z,2013,12,2013-12-07T05:00:00Z,,2014-01-05T03:25:10Z,,0,0,09000064814affab
FDA-1975-N-0012-0294,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures  for  OTC Topical Antiseptic Drug Products Request Labeling Changes  re Aero Med Beijing China,Other,Letter(s),2013-12-07T05:00:00Z,2013,12,2013-12-07T05:00:00Z,,2014-01-05T03:25:10Z,,0,0,09000064814affa8
FDA-1975-N-0012-0292,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes  re Affassco Shanghai China,Other,Letter(s),2013-12-07T05:00:00Z,2013,12,2013-12-07T05:00:00Z,,2014-01-05T03:25:10Z,,0,0,09000064814affaa
FDA-1975-N-0012-0293,FDA,FDA-1975-N-0012,FDA CDER Letter to Manufactures  for OTC Topical Antiseptic Drug Products Request Labeling Changes  re Aero Med Jiangsu China,Other,Letter(s),2013-12-07T05:00:00Z,2013,12,2013-12-07T05:00:00Z,,2014-01-05T03:25:10Z,,0,0,09000064814affa9
FDA-1975-N-0012-0280,FDA,FDA-1975-N-0012,"Letter from FDA/CDER to Century Pharmaceuticals, Inc. re FDA-1975-N-0012-0273/CP18",Other,Letter(s),2013-06-27T04:00:00Z,2013,6,2013-06-27T04:00:00Z,,2017-12-14T20:20:59Z,,0,0,09000064805c1d36
FDA-1975-N-0012-0279,FDA,FDA-1975-N-0012,"Appearance Request from Alcavis International, Inc. (Alston & Bird, LLP)",Other,Appearance Request,2013-06-25T04:00:00Z,2013,6,2013-06-25T04:00:00Z,,2017-12-14T17:35:02Z,,0,0,09000064805c1d33
FDA-1975-N-0012-0278,FDA,FDA-1975-N-0012,Correction Letter from Colgate-Palmolive Company to FDA,Other,Correction(s),2013-06-25T04:00:00Z,2013,6,,,2017-10-31T14:23:20Z,,0,0,09000064805c1c9c
FDA-1975-N-0012-0274,FDA,FDA-1975-N-0012,Citizen Petition from Hy-Gene Biomedical Corporation,Other,Citizen Petition,2013-05-07T04:00:00Z,2013,5,2013-05-07T04:00:00Z,,2017-11-29T17:31:18Z,,0,0,09000064805c1cc0
FDA-1975-N-0012-0271,FDA,FDA-1975-N-0012,Supplement from Ciba Specialty Chemicals Corporation,Other,Supplement (SUP),2013-02-01T05:00:00Z,2013,2,2013-02-01T05:00:00Z,,2017-11-29T17:53:28Z,,0,0,09000064805c1cd6
FDA-1975-N-0012-0273,FDA,FDA-1975-N-0012,"Citizen Petition from Century Pharmaceuticals, Inc.",Other,Citizen Petition,2013-02-01T05:00:00Z,2013,2,2013-02-01T05:00:00Z,,2017-10-31T13:51:03Z,,0,0,09000064805c1d1e
FDA-1975-N-0012-0270,FDA,FDA-1975-N-0012,"Memorandum of Meeting Alcavis International, Inc., Follow-up Letter to Meeting February 12, 2004",Other,Letter(s),2013-02-01T05:00:00Z,2013,2,2013-02-01T05:00:00Z,,2017-10-30T14:59:43Z,,0,0,09000064805c1ca7
FDA-1975-N-0012-0247,FDA,FDA-1975-N-0012,Letter from FDA/CDER to Bayer Corporation,Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T16:11:47Z,,0,0,09000064805c1b49
FDA-1975-N-0012-0245,FDA,FDA-1975-N-0012,"Citizen Petition from Soap & Detergent Association & Cosmetic, Toiletry & Fragrance Association - References (Books 1-4)",Supporting & Related Material,Background Material,2013-01-13T05:00:00Z,2013,1,,,2017-11-28T18:21:41Z,,0,0,0900006480ab856a
FDA-1975-N-0012-0241,FDA,FDA-1975-N-0012,Supplement from International Laboratory Technology Corporation (ILTC),Other,Supplement (SUP),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-11-27T16:58:54Z,,0,0,09000064805c1b42
FDA-1975-N-0012-0257,FDA,FDA-1975-N-0012,"Letter from FDA/CDER to the Soap & Detergent Association & Cosmetic, Toiletry & Fragrance Association, Inc.",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-25T19:06:10Z,,0,0,09000064805c1b5c
FDA-1975-N-0012-0252,FDA,FDA-1975-N-0012,Answer from FDA/CDER Response to Rural Industries Research & Development Corporation (RIRDC),Other,Answer,2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T16:29:35Z,,0,0,09000064805c1b57
FDA-1975-N-0012-0233,FDA,FDA-1975-N-0012,"Letter from FDA/CDER to Cosmetic, Toiletry & Fragrance Association, Inc.",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T16:06:03Z,,0,0,09000064805c1b3f
FDA-1975-N-0012-0237,FDA,FDA-1975-N-0012,Citizen Petition from Alcavis International,Other,Citizen Petition,2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-11-24T22:11:04Z,,0,0,09000064805c1b36
FDA-1975-N-0012-0263,FDA,FDA-1975-N-0012,"Supplement from Microbiotest, Inc.",Other,Supplement (SUP),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-11-27T21:47:36Z,,0,0,09000064805c1b6a
FDA-1975-N-0012-0264,FDA,FDA-1975-N-0012,"Letter from Patton Boggs on behalf of Lonza, Inc. to FDA /CDER",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-30T15:44:34Z,,0,0,09000064805c1b6f
FDA-1975-N-0012-0260,FDA,FDA-1975-N-0012,"Letter from Buchanan Ingersoll on behalf of Alcavis International, Inc. to FDA/CDER",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-30T15:25:18Z,,0,0,09000064805c1b60
FDA-1975-N-0012-0248,FDA,FDA-1975-N-0012,"Letter from FDA/CDER Interim Response to Lonza, Inc.",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T16:17:13Z,,0,0,09000064805c1b50
FDA-1975-N-0012-0262,FDA,FDA-1975-N-0012,"Supplement from Buchanan Ingersoll on behalf of Alcavis International, Inc.",Other,Supplement (SUP),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-11-28T14:35:46Z,,0,0,09000064805c1b62
FDA-1975-N-0012-0250,FDA,FDA-1975-N-0012,"Letter from Alcavis International, Inc. to FDA",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,,,2017-10-24T16:20:51Z,,0,0,09000064805c1b52
FDA-1975-N-0012-0251,FDA,FDA-1975-N-0012,Letter from Rural Industries Research & Development Corporation (RIRDC) to FDA,Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T16:26:25Z,,0,0,09000064805c1b56
FDA-1975-N-0012-0244,FDA,FDA-1975-N-0012,Supplement from International Laboratory Technology Corporation (ILTC),Other,Supplement (SUP),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T16:13:41Z,,0,0,09000064805c1b4f
FDA-1975-N-0012-0243,FDA,FDA-1975-N-0012,"Supplement from Lonza, Inc.",Other,Supplement (SUP),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-11-27T18:06:00Z,,0,0,09000064805c1b4a
FDA-1975-N-0012-0254,FDA,FDA-1975-N-0012,Letter from Thursday Plantation to FDA/CDER,Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-25T18:55:45Z,,0,0,09000064805c1b59
FDA-1975-N-0012-0258,FDA,FDA-1975-N-0012,"Citizen Petition from Soap & Detergent Association & Cosmetic, Toiletry & Fragrance Association, Inc.",Other,Citizen Petition,2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-26T13:25:52Z,,0,0,09000064805c1b5d
FDA-1975-N-0012-0231,FDA,FDA-1975-N-0012,Letter from FDA/CDER to International Laboratory Technology Corporation,Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T16:04:10Z,,0,0,09000064805c1b3d
FDA-1975-N-0012-0265,FDA,FDA-1975-N-0012,"Supplement from Lonza, Inc.",Other,Supplement (SUP),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-27T15:30:04Z,,0,0,09000064805c1ca0
FDA-1975-N-0012-0235,FDA,FDA-1975-N-0012,Letter from FDA/CDER to Clariant Corporation,Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T16:09:58Z,,0,0,09000064805c1b41
FDA-1975-N-0012-0229,FDA,FDA-1975-N-0012,Letter from FDA/Office of the Commissioner to The Procter & Gamble Company,Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T14:06:27Z,,0,0,09000064805c1b38
FDA-1975-N-0012-0230,FDA,FDA-1975-N-0012,Letter from FDA/Office of the Commissioner to Rural Industries Research & Development Corporation,Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-27T19:19:42Z,,0,0,09000064805c1b39
FDA-1975-N-0012-0249,FDA,FDA-1975-N-0012,"Letter from FDA/Office of the Commissioner to Alcavis International, Inc.",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T16:19:49Z,,0,0,09000064805c1b51
FDA-1975-N-0012-0256,FDA,FDA-1975-N-0012,Letter from FDA/CDER to Clariant Corporation,Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-25T19:03:56Z,,0,0,09000064805c1b5b
FDA-1975-N-0012-0253,FDA,FDA-1975-N-0012,"Letter from BioScience Laboratories, Inc. to FDA/CDER",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-27T13:17:39Z,,0,0,09000064805c1b58
FDA-1975-N-0012-0261,FDA,FDA-1975-N-0012,"Letter from Buchanan Ingersoll on behalf of Alcavis International, Inc. to FDA/CDER",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-30T15:26:35Z,,0,0,09000064805c1b61
FDA-1975-N-0012-0255,FDA,FDA-1975-N-0012,"Letter from FDA/CDER to The Soap & Detergent Association & Cosmetic, Toiletry & Fragrance Association, Inc.",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-30T15:20:03Z,,0,0,09000064805c1b5a
FDA-1975-N-0012-0259,FDA,FDA-1975-N-0012,"Acknowledgement Letter from FDA/DDM  to The Cosmetic, Toiletry and Fragrance Association and the Soap and Detergent Association",Other,Acknowledgement Letter/Receipt,2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-11-24T17:56:30Z,,0,0,09000064805c1b5e
FDA-1975-N-0012-0238,FDA,FDA-1975-N-0012,"Citizen Petition from Lonza, Inc.",Other,Citizen Petition,2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-11-27T15:53:01Z,,0,0,09000064805c1b3b
FDA-1975-N-0012-0232,FDA,FDA-1975-N-0012,"Letter from FDA/CDER to Woodward Laboratories, Inc.",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T16:05:05Z,,0,0,09000064805c1b3e
FDA-1975-N-0012-0239,FDA,FDA-1975-N-0012,Acknowledgement Letter to Alcavis International,Other,Acknowledgement Letter/Receipt,2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-26T19:33:41Z,,0,0,09000064805c1b37
FDA-1975-N-0012-0228,FDA,FDA-1975-N-0012,"Acknowledgment Letter from FDA/DDM to the Soap & Detergent Association & Cosmetic, Toiletry & Fragrance Association",Other,Acknowledgement Letter/Receipt,2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-20T18:54:13Z,,0,0,09000064805c1b1b
FDA-1975-N-0012-0242,FDA,FDA-1975-N-0012,Protocol Review from Clariant Corporation,Other,Protocol Review,2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-11-27T18:05:25Z,,0,0,09000064805c1b43
FDA-1975-N-0012-0246,FDA,FDA-1975-N-0012,"Letter from FDA/CDER to The Soap & Detergent Association & Cosmetic, Toiletry & Fragrance Association, Inc.",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T16:10:49Z,,0,0,09000064805c1b48
FDA-1975-N-0012-0236,FDA,FDA-1975-N-0012,"Memorandum of Telephone Conversion between FDA/CDER and International Laboratory Testing, May 3, 2002",Other,Memorandum,2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-11-21T19:57:30Z,,0,0,09000064805c1b3a
FDA-1975-N-0012-0234,FDA,FDA-1975-N-0012,"Letter from FDA/CDER to Cosmetic, Toiletry & Fragrance Association, Inc.",Other,Letter(s),2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-10-24T16:07:53Z,,0,0,09000064805c1b40
FDA-1975-N-0012-0240,FDA,FDA-1975-N-0012,"Acknowledgment Letter from FDA/DDM to Lonza, Inc. (Patton Boggs, LLP)",Other,Acknowledgement Letter/Receipt,2013-01-13T05:00:00Z,2013,1,2013-01-13T05:00:00Z,,2017-11-27T15:57:21Z,,0,0,09000064805c1b3c
FDA-1975-N-0012-0227,FDA,FDA-1975-N-0012,"Citizen Petition from Soap & Detergent Association & Cosmetic, Toiletry & Fragrance Association",Other,Citizen Petition,2013-01-12T05:00:00Z,2013,1,2013-01-12T05:00:00Z,,2017-11-21T18:42:23Z,,0,0,09000064805c1b07